How many valid measurements are necessary to assess liver fibrosis using fibroscan ® in patients with chronic viral hepatitis? An analysis of subjects with at least 10 valid measurements

Yonsei Medical Journal

Volumn 53, Issue 2, 2012, Pages 337-345

  Jang, Hui Won ^a   Kim, Seung Up ^a,b   Park, Jun Yong ^a,b   Ahn, Sang Hoon ^a,b,c   Han, Kwang Hyub ^a,b,c   Chon, Chae Yoon ^a,b   Park, Young Nyun ^a,b,c   Choi, Eun Hee ^a   Kim, Do Young ^a,b  

^a Yonsei University College of Medicine   (South Korea)

^b Liver Cirrhosis Clinical Research Center   (South Korea)

^c Brain Korea 21 Project for Medical Science   (South Korea)

Author keywords

Chronic hepatitis B; Chronic hepatitis C; Chronic viral hepatitis; Fibroscan; Liver stiffness measurement; Transient elastography

Indexed keywords

ALANINE AMINOTRANSFERASE;

ADULT; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANTIVIRAL THERAPY; ARTICLE; BODY MASS; CHRONIC HEPATITIS; DIAGNOSTIC ACCURACY; DIGESTIVE TRACT PARAMETERS; ELASTICITY; ELASTOGRAPHY; FEMALE; HEPATITIS B; HEPATITIS C; HISTOPATHOLOGY; HUMAN; LIVER BIOPSY; LIVER EXAMINATION; LIVER FIBROSIS; LIVER STIFFNESS MEASUREMENT; MAJOR CLINICAL STUDY; MALE; PREDICTOR VARIABLE; PROSPECTIVE STUDY; SCORING SYSTEM; VALIDITY;

ADULT; ALANINE TRANSAMINASE; FEMALE; HEPATITIS B, CHRONIC; HUMANS; LIVER; LIVER CIRRHOSIS; MALE; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84863182662     PISSN: 05135796     EISSN: None     Source Type: Journal    
DOI: 10.3349/ymj.2012.53.2.337     Document Type: Article

References (27)

1. Castéra L, Vergniol J, Foucher J, Le Bail B, Chanteloup E, Haaser M, et al. Prospective comparison of transient elastography, Fibrotest, APRI, and liver biopsy for the assessment of fibrosis in chronic hepatitis C. Gastroenterology 2005;128:343-50.
2. Ziol M, Handra-Luca A, Kettaneh A, Christidis C, Mal F, Kazemi F, et al. Noninvasive assessment of liver fibrosis by measurement of stiffiness in patients with chronic hepatitis C. Hepatology 2005;41:48-54.
3. Marcellin P, Ziol M, Bedossa P, Douvin C, Poupon R, de Léding-hen V, et al. Non-invasive assessment of liver fibrosis by stiffiness measurement in patients with chronic hepatitis B. Liver Int 2009;29:242-7.
4. Kim SU, Kim do Y, Park JY, Lee JH, Ahn SH, Kim JK, et al. How can we enhance the performance of liver stiffiness measurement using FibroScan in diagnosing liver cirrhosis in patients with chronic hepatitis B? J Clin Gastroenterol 2010;44:66-71.
5. Fraquelli M, Rigamonti C, Casazza G, Conte D, Donato MF, Ron-chi G, et al. Reproducibility of transient elastography in the evaluation of liver fibrosis in patients with chronic liver disease. Gut 2007;56:968-73.
6. Roulot D, Czernichow S, Le Clésiau H, Costes JL, Vergnaud AC, Beaugrand M. Liver stiffiness values in apparently healthy subjects: influence of gender and metabolic syndrome. J Hepatol 2008;48:606-13.
7. Lucidarme D, Foucher J, Le Bail B, Vergniol J, Castera L, Du-burque C, et al. Factors of accuracy of transient elastography (fibroscan) for the diagnosis of liver fibrosis in chronic hepatitis C. Hepatology 2009;49:1083-9.
8. Kim SU, Seo YS, Cheong JY, Kim MY, Kim JK, Um SH, et al. Factors that affect the diagnostic accuracy of liver fibrosis measurement by Fibroscan in patients with chronic hepatitis B. Aliment Pharmacol Ther 2010;32:498-505.
9. Kettaneh A, Marcellin P, Douvin C, Poupon R, Ziol M, Beaugrand M, et al. Features associated with success rate and performance of FibroScan measurements for the diagnosis of cirrhosis in HCV patients: a prospective study of 935 patients. J Hepatol 2007;46: 628-34.
10. Myers RP, Crotty P, Pomier-Layrargues G, Ma M, Urbanski SJ, Elkashab M. Prevalence, risk factors and causes of discordance in fibrosis staging by transient elastography and liver biopsy. Liver Int 2010;30:1471-80.
11. Kim SU, Kim do Y, Lee CK, Park JY, Kim SH, Kim HM, et al. Ascitic fuid infection in patients with hepatitis B virus-related liver cirrhosis: culture-negative neutrocytic ascites versus spontaneous bacterial peritonitis. J Gastroenterol Hepatol 2010;25:122-8.
12. Bedossa P, Dargére D, Paradis V. Sampling variability of liver fibrosis in chronic hepatitis C. Hepatology 2003;38:1449-57.
13. Lebray P, Varnous S, Charlotte F, Varaut A, Poynard T, Ratziu V. Liver stiffiness is an unreliable marker of liver fibrosis in patients with cardiac insuffciency. Hepatology 2008;48:2089.
14. Sandrin L, Fourquet B, Hasquenoph JM, Yon S, Fournier C, Mal F, et al. Transient elastography: a new noninvasive method for assessment of hepatic fibrosis. Ultrasound Med Biol 2003;29:1705-13.
15. Batts KP, Ludwig J. Chronic hepatitis. An update on terminology and reporting. Am J Surg Pathol 1995;19:1409-17.
16. Brunt EM, Janney CG, Di Bisceglie AM, Neuschwander-Tetri BA, Bacon BR. Nonalcoholic steatohepatitis: a proposal for grading and staging the histological lesions. Am J Gastroenterol 1999;94:2467-74.
17. Talwalkar JA, Kurtz DM, Schoenleber SJ, West CP, Montori VM. Ultrasound-based transient elastography for the detection of hepatic fibrosis: systematic review and meta-analysis. Clin Gastro-enterol Hepatol 2007;5:1214-20.
18. Friedrich-Rust M, Ong MF, Martens S, Sarrazin C, Bojunga J, Zeuzem S, et al. Performance of transient elastography for the staging of liver fibrosis: a meta-analysis. Gastroenterology 2008; 134:960-74.
19. Stebbing J, Farouk L, Panos G, Anderson M, Jiao LR, Mandalia S, et al. A meta-analysis of transient elastography for the detection of hepatic fibrosis. J Clin Gastroenterol 2010;44:214-9.
20. Chan HL, Wong GL, Choi PC, Chan AW, Chim AM, Yiu KK, et al. Alanine aminotransferase-based algorithms of liver stiffiness measurement by transient elastography (Fibroscan) for liver fibrosis in chronic hepatitis B. J Viral Hepat 2009;16:36-44.
21. Wang JH, Changchien CS, Hung CH, Eng HL, Tung WC, Kee KM, et al. FibroScan and ultrasonography in the prediction of hepatic fibrosis in patients with chronic viral hepatitis. J Gastroenterol 2009;44:439-46.
22. Takeda T, Yasuda T, Nakayama Y, Nakaya M, Kimura M, Yamashita M, et al. Usefulness of noninvasive transient elastography for assessment of liver fibrosis stage in chronic hepatitis C. World J Gastroenterol 2006;12:7768-73.
23. Nitta Y, Kawabe N, Hashimoto S, Harata M, Komura N, Ko-bayashi K, et al. Liver stiffiness measured by transient elastography correlates with fibrosis area in liver biopsy in patients with chronic hepatitis C. Hepatol Res 2009;39:675-84.
24. DeLong ER, DeLong DM, Clarke-Pearson DL. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 1988;44:837-45.
25. Yuen MF, Yuan HJ, Hui CK, Wong DK, Wong WM, Chan AO, et al. A large population study of spontaneous HBeAg seroconver-sion and acute exacerbation of chronic hepatitis B infection: implications for antiviral therapy. Gut 2003;52:416-9.
26. Poynard T, Halfon P, Castera L, Munteanu M, Imbert-Bismut F, Ratziu V, et al. Standardization of ROC curve areas for diagnostic evaluation of liver fibrosis markers based on prevalences of fibrosis stages. Clin Chem 2007;53:1615-22.
27. Liaw YF. Hepatitis fares and hepatitis B e antigen seroconversion: implication in anti-hepatitis B virus therapy. J Gastroenterol Hepatol 2003;18:246-52.